The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand flag Thailand · Delayed Price · Currency is THB
28.50
-0.50 (-1.72%)
Aug 11, 2026, 11:21 AM ICT

BKK:KLINIQ Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
400.03363.7322.19288.62205.49129.26
Depreciation & Amortization
344.45333.12282.3194.6114281.19
Loss (Gain) From Sale of Assets
11.155.985.17-0.030.442.29
Asset Writedown & Restructuring Costs
----0-0.03-
Other Operating Activities
-370.46-353.12-463.93-342.62-216.48-194.24
Change in Accounts Receivable
-0.41-5.425.08-9.56-1.41-0.59
Change in Inventory
-71.31-115.96-82.63-70.99-35.5118.53
Change in Accounts Payable
3081.3334.5352.6437.1826.35
Change in Unearned Revenue
463.2414.38451.73326.59334.25183.82
Change in Other Net Operating Assets
-66.42-63.24-2.46-53.33-57.98-8.03
Operating Cash Flow
740.15660.77551.98385.92407.96238.56
Operating Cash Flow Growth
12.55%19.71%43.03%-5.40%71.01%-3.91%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-299.25-300.15-571.67-366.52-225.79-72.92
Sale of Property, Plant & Equipment
18.1820.7839.340.58-2.6
Sale (Purchase) of Intangibles
-0.93-0.7-1.13-0.59-1.16-1.12
Investment in Securities
-67.05128.03529.37-60.1-1,000-
Other Investing Activities
-4.18-5.5819.895.260.5220.06
Investing Cash Flow
-353.23-157.6115.79-421.37-1,226-51.37

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Repaid
------12.94
Long-Term Debt Repaid
--137.36-120.39-89.51-63.39-27.63
Total Debt Repaid
-147.1-137.36-120.39-89.51-63.39-40.57
Net Debt Issued (Repaid)
-147.1-137.36-120.39-89.51-63.39-40.57
Issuance of Common Stock
2020--1,470-
Common Dividends Paid
-319-319-308-231-153.2-80
Other Financing Activities
-20----46.4-
Financing Cash Flow
-466.1-436.36-428.39-320.511,207-120.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-79.1866.8139.38-355.96388.5466.62

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
440.9360.62-19.719.39182.17165.64
Free Cash Flow Growth
122.77%---89.35%9.97%65.76%
Free Cash Flow Margin
11.52%10.14%-0.66%0.85%11.11%17.44%
Free Cash Flow Per Share
2.001.64-0.090.091.071.03
Levered Free Cash Flow
404.46295.05-51.44-20.98175.4167.45
Unlevered Free Cash Flow
421.32311.51-36.5-11.54182.06170.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
26.9526.3423.915.110.664.32
Cash Income Tax Paid
84.2384.2764.4255.2835.3922.17
Change in Working Capital
355.06311.08406.25245.35276.53220.06